Prostate specific antigen screening declines after 2012 USPSTF recommendations

Researchers have assessed the impact of the 2012 U.S. Preventive Services Task Force recommendations against routine prostate specific antigen (PSA) cancer screenings, which cited evidence that the risks of screening outweigh the benefits. Results of the current study indicate that the USPSTF recommendations have resulted in a decrease in the number of PSA screenings ordered by doctors, with the greatest decline seen among urologists.img src="http://feeds.feedburner.com/~r/sciencedaily/top_news/top_health/~4/I7LcKPxCP6k" height="1" width="1"/